<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171224038033N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-06-05</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>A Comparative Study on the Comparison of Current Infant formula in Iranian Market</public_title>
      <acronym></acronym>
      <scientific_title>A Comparative Study on the Comparison of Current Infant formula in Iranian Market</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-06-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>10</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/29594</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Prevention, Randomization description: At the first, the participants are divided into two groups of four and a group of two randomly into a draw method, Blinding description: The participants in the study did not know the type of tested milk (between the three studied types).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Dental caries.</hc_freetext>
      <i_freetext>Intervention 1: The first itervention is Aptamil 3 infant formula. At first, the participants are divided into two groups of four and two using simple random method and the interval of one week is considered as washout. In this way, each group randomly uses one of the products per week. Intervention is performed with 10 cc of one of the Infant formulas of Aptamil 3, NAN 3 and Bebelac 3 with one-week interval. The Aptamil 3 Infant formula is manufactured by Nutrition Company, NAN 3 made by Milupa, and Bebelac 3 is made by Nestle Corporation. The ingredients of the products studied are based on the information on the packaging, including protein, energy, casein, fat, linoleic acid, AA, DHA, carbohydrate, lactose, etc., as described in the table. In each session, the pH of the dental plaque base is measured by the testator at the site, in the area between the distal surface of the first premolar and the second mesenteric surface of the premolars, in all four quadrants of the mouth. The person tested then holds ten cubic meters of the infant formula in mouth for two minutes and then swallows. The pH of the plaque at designated sites of all four quadrants is measured at five, ten, twenty and sixty minutes after the application of the solution using Metrohm Microelectrode (Ω Metrohm Switzerland LL micro glass electrode) connected to the digital PH Meter (Swiss- Metrohm). It should be noted that the microelectrode is washed prior to the start of each test and at intervals of each reading with a solution 3 KCL model (pH = 7) calibrated with distilled water flow. Meanwhile, for disinfection of the electrode for intervals between the subjects, 2% glutaraldehyde solution is used for 20 minutes. The average pH at the time of the examination, separately the three materials tested in the all quadrants are determined. The results of the study were analyzed by Repeated measure ANOVA with a significance level of p &lt;0.05. In evry 100gr of Apyamil 3 infant formula: Energy : 460 Kcal -  Protein : 15.4 gr - Whey protein : 5.8 gr -  Casein : 9.5 gr -  Fat : 20.3 gr - Linoleic acid : 2693 mg -  Alpha Linoleic Acid : 496 mg -  carbohydrates: 52.6 g -  Lactose : 50 g -  Fiber : 3.8 g – Sodium : 220 mg – Potassium : 710 mg -  Chlorine : 460 mg -  Calcium : 640 mg -  Phosphorus : 406 mg -  Ratio of calcium and phosphorus : 1.6 -  Magnesium : 53 mg – Iron : 7 mg -  Zinc : 4.3 mg -  Copper :280 μg – Iodine : 101 μg -  Manganese : 52 μg -  Selenium : 13 μg -  Vitamin A : 447 μg -  Vitamin D : 10.7  μg - Vitamin B1 : 412 μg - Vitamin B2 : 1000 μg -  Vitamin B6 : 326 μg -  Vitamin B12 : 1.6 μg -  Biotin : 14 μg - Folic acid : 87 μg – Niacin : 3.2 mg – Pantothenic Acid : 3072 μg -  Vitamin C : 66 mg - Vitamin K : 38  μg - Vitamin E : 8 mg – Cytidine : 7.4 mg – Uridine : 5.3 mg – Adenosine : 4.6 mg – Guanosine : 1.6 mg -  Inosine : 3.1 mg – Taurine : 37 mg – Choline : 88 mg – Inositol : 35 mg - L-Carnitine : 9 mg. Intervention 2: The first itervention is Nan 3 infant formula.At first, the participants are divided into two groups of four and two using simple random method and the interval of one week is considered as washout. In this way, each group randomly uses one of the products per week. Intervention is performed with 10 cc of one of the Infant formulas of Aptamil 3, NAN 3 and Bebelac 3 with one-week interval. The Aptamil 3 Infant formula is manufactured by Nutrition Company, NAN 3 made by Milupa, and Bebelac 3 is made by Nestle Corporation. The ingredients of the products studied are based on the information on the packaging, including protein, energy, casein, fat, linoleic acid, AA, DHA, carbohydrate, lactose, etc., as described in the table. In each session, the pH of the dental plaque base is measured by the testator at the site, in the area between the distal surface of the first premolar and the second mesenteric surface of the premolars, in all four quadrants of the mouth. The person tested then holds ten cubic meters of the infant formula in mouth for two minutes and then swallows. The pH of the plaque at designated sites of all four quadrants is measured at five, ten, twenty and sixty minutes after the application of the solution using Metrohm Microelectrode (Ω Metrohm Switzerland LL micro glass electrode) connected to the digital PH Meter (Swiss- Metrohm). It should be noted that the microelectrode is washed prior to the start of each test and at intervals of each reading with a solution 3 KCL model (pH = 7) calibrated with distilled water flow. Meanwhile, for disinfection of the electrode for intervals between the subjects, 2% glutaraldehyde solution is used for 20 minutes. The average pH at the time of the examination, separately the three materials tested in the all quadrants are determined. The results of the study were analyzed by Repeated measure ANOVA with a significance level of p &lt;0.05. Energy : 497 Kcal -  Protein : 14.9 gr -  Fat : 23.3 gr - Linoleic acid : 3.20 gr  -  Alpha Linoleic Acid : 400 mg -  carbohydrates: 57 g -  Lactose : 50 gr – Sodium :160 mg – Potassium : 520 mg -  Chlorine : 340 mg -  Calcium : 500 mg -  Phosphorus : 350 mg -   Magnesium :46 mg – Iron : 7.5 mg -  Zinc : 6 mg -  Copper :0.3 mg – Iodine : 115 μg -  Manganese : 25 μg -  Selenium : 10.5 μg -  Vitamin A : 390 μg -  Vitamin D : 7.25  μg - Vitamin B1 : 0.84 μg - Vitamin B2 : 1.32 mg -  Vitamin B6 : 0.4  mg -  Vitamin B12 : 1.1 μg -  Biotin : 14.2 μg - Folic acid : 108 μg – Niacin : 3.7 mg – Pantothenic Acid :4.65 mg -  Vitamin C : 60 mg - Vitamin K : 40  μg - Vitamin E : 8 mg  – Choline : 70 mg – Inositol : 36 mg. Intervention 3: The first itervention is Bebelac 3 infant formula. At first, the participants are divided into two groups of four and two using simple random method and the interval of one week is considered as washout. In this way, each group randomly uses one of the products per week. Intervention is performed with 10 cc of one of the Infant formulas of Aptamil 3, NAN 3 and Bebelac 3 with one-week interval. The Aptamil 3 Infant formula is manufactured by Nutrition Company, NAN 3 made by Milupa, and Bebelac 3 is made by Nestle Corporation. The ingredients of the products studied are based on the information on the packaging, including protein, energy, casein, fat, linoleic acid, AA, DHA, carbohydrate, lactose, etc., as described in the table. In each session, the pH of the dental plaque base is measured by the testator at the site, in the area between the distal surface of the first premolar and the second mesenteric surface of the premolars, in all four quadrants of the mouth. The person tested then holds ten cubic meters of the infant formula in mouth for two minutes and then swallows. The pH of the plaque at designated sites of all four quadrants is measured at five, ten, twenty and sixty minutes after the application of the solution using Metrohm Microelectrode (Ω Metrohm Switzerland LL micro glass electrode) connected to the digital PH Meter (Swiss- Metrohm). It should be noted that the microelectrode is washed prior to the start of each test and at intervals of each reading with a solution 3 KCL model (pH = 7) calibrated with distilled water flow. Meanwhile, for disinfection of the electrode for intervals between the subjects, 2% glutaraldehyde solution is used for 20 minutes. The average pH at the time of the examination, separately the three materials tested in the all quadrants are determined. The results of the study were analyzed by Repeated measure ANOVA with a significance level of p &lt;0.05. Energy : 456 Kcal -  Protein : 15 gr - Whey protein : 6 gr -  Casein : 9 gr -  Fat : 19.6 gr - Linoleic acid : 2640 mg -  Alpha Linoleic Acid : 489 mg -  carbohydrates: 53.3 g -  Lactose : 50.6 g -  Fiber : 3.7 g – Sodium : 182 mg – Potassium : 730 mg -  Chlorine : 536 mg -  Calcium : 638 mg -  Phosphorus : 410 mg -  Ratio of calcium and phosphorus : 1.6 -  Magnesium : 49 mg – Iron : 6.7 mg -  Zinc : 4.4 mg -  Copper :268 μg – Iodine : 105 μg -  Manganese : 45 μg -  Selenium : 13 μg -  Vitamin A : 436 μg -  Vitamin D : 9.5  μg - Vitamin B1 : 416 μg - Vitamin B2 : 822 μg -  Vitamin B6 : 330 μg -  Vitamin B12 : 1.3 μg -  Biotin : 14 μg - Folic acid : 86 μg – Niacin : 3.1 mg – Pantothenic Acid : 2954 μg -  Vitamin C : 61 mg - Vitamin K : 33  μg - Vitamin E : 7.6 mg – Cytidine : 7.1 mg – Uridine : 5 mg – Adenosine : 4.4 mg – Guanosine : 1.5 mg -  Inosine : 2.9 mg – Taurine : 34 mg – Choline : 86 mg – Inositol : 32 mg - L-Carnitine : 9.2 mg.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sara Bahman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7th Floor, Bldg No.2, Shahid Beheshti University of Medical Sciences, Arabi Ave, Daneshjoo Blvd, Velenjak, Chamran highway, Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>19839-63113</zip>
        <telephone>+98 21 2242 3163</telephone>
        <email>sara.bahman@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Ahmadian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7th Floor, Bldg No.2, Shahid Beheshti University of Medical Sciences, Arabi Ave, Daneshjoo Blvd, Velenjak, Chamran highway, Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>19839-63113</zip>
        <telephone>+98 21 2217 5350</telephone>
        <email>f.ahmadianb@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Complete systemic health
Not taken antibiotics two weeks before starting the test
No special diet
Not diagnosed with Xerostomia
No use of orthodontic or prosthetic appliance</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Smoking
Pregnancy
Diagnosed Periodontal disease
Active dental caries
Tooth filling in the examined area</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first itervention is Aptamil 3 infant formula. At first, the participants are divided into two groups of four and two using simple random method and the interval of one week is considered as washout. In this way, each group randomly uses one of the products per week. Intervention is performed with 10 cc of one of the Infant formulas of Aptamil 3, NAN 3 and Bebelac 3 with one-week interval. The Aptamil 3 Infant formula is manufactured by Nutrition Company, NAN 3 made by Milupa, and Bebelac 3 is made by Nestle Corporation. The ingredients of the products studied are based on the information on the packaging, including protein, energy, casein, fat, linoleic acid, AA, DHA, carbohydrate, lactose, etc., as described in the table. In each session, the pH of the dental plaque base is measured by the testator at the site, in the area between the distal surface of the first premolar and the second mesenteric surface of the premolars, in all four quadrants of the mouth. The person tested then holds ten cubic meters of the infant formula in mouth for two minutes and then swallows. The pH of the plaque at designated sites of all four quadrants is measured at five, ten, twenty and sixty minutes after the application of the solution using Metrohm Microelectrode (Ω Metrohm Switzerland LL micro glass electrode) connected to the digital PH Meter (Swiss- Metrohm). It should be noted that the microelectrode is washed prior to the start of each test and at intervals of each reading with a solution 3 KCL model (pH = 7) calibrated with distilled water flow. Meanwhile, for disinfection of the electrode for intervals between the subjects, 2% glutaraldehyde solution is used for 20 minutes. The average pH at the time of the examination, separately the three materials tested in the all quadrants are determined. The results of the study were analyzed by Repeated measure ANOVA with a significance level of p &lt;0.05. In evry 100gr of Apyamil 3 infant formula: Energy : 460 Kcal -  Protein : 15.4 gr - Whey protein : 5.8 gr -  Casein : 9.5 gr -  Fat : 20.3 gr - Linoleic acid : 2693 mg -  Alpha Linoleic Acid : 496 mg -  carbohydrates: 52.6 g -  Lactose : 50 g -  Fiber : 3.8 g – Sodium : 220 mg – Potassium : 710 mg -  Chlorine : 460 mg -  Calcium : 640 mg -  Phosphorus : 406 mg -  Ratio of calcium and phosphorus : 1.6 -  Magnesium : 53 mg – Iron : 7 mg -  Zinc : 4.3 mg -  Copper :280 μg – Iodine : 101 μg -  Manganese : 52 μg -  Selenium : 13 μg -  Vitamin A : 447 μg -  Vitamin D : 10.7  μg - Vitamin B1 : 412 μg - Vitamin B2 : 1000 μg -  Vitamin B6 : 326 μg -  Vitamin B12 : 1.6 μg -  Biotin : 14 μg - Folic acid : 87 μg – Niacin : 3.2 mg – Pantothenic Acid : 3072 μg -  Vitamin C : 66 mg - Vitamin K : 38  μg - Vitamin E : 8 mg – Cytidine : 7.4 mg – Uridine : 5.3 mg – Adenosine : 4.6 mg – Guanosine : 1.6 mg -  Inosine : 3.1 mg – Taurine : 37 mg – Choline : 88 mg – Inositol : 35 mg - L-Carnitine : 9 mg</i_keyword>
      <i_keyword>The first itervention is Nan 3 infant formula.At first, the participants are divided into two groups of four and two using simple random method and the interval of one week is considered as washout. In this way, each group randomly uses one of the products per week. Intervention is performed with 10 cc of one of the Infant formulas of Aptamil 3, NAN 3 and Bebelac 3 with one-week interval. The Aptamil 3 Infant formula is manufactured by Nutrition Company, NAN 3 made by Milupa, and Bebelac 3 is made by Nestle Corporation. The ingredients of the products studied are based on the information on the packaging, including protein, energy, casein, fat, linoleic acid, AA, DHA, carbohydrate, lactose, etc., as described in the table. In each session, the pH of the dental plaque base is measured by the testator at the site, in the area between the distal surface of the first premolar and the second mesenteric surface of the premolars, in all four quadrants of the mouth. The person tested then holds ten cubic meters of the infant formula in mouth for two minutes and then swallows. The pH of the plaque at designated sites of all four quadrants is measured at five, ten, twenty and sixty minutes after the application of the solution using Metrohm Microelectrode (Ω Metrohm Switzerland LL micro glass electrode) connected to the digital PH Meter (Swiss- Metrohm). It should be noted that the microelectrode is washed prior to the start of each test and at intervals of each reading with a solution 3 KCL model (pH = 7) calibrated with distilled water flow. Meanwhile, for disinfection of the electrode for intervals between the subjects, 2% glutaraldehyde solution is used for 20 minutes. The average pH at the time of the examination, separately the three materials tested in the all quadrants are determined. The results of the study were analyzed by Repeated measure ANOVA with a significance level of p &lt;0.05. Energy : 497 Kcal -  Protein : 14.9 gr -  Fat : 23.3 gr - Linoleic acid : 3.20 gr  -  Alpha Linoleic Acid : 400 mg -  carbohydrates: 57 g -  Lactose : 50 gr – Sodium :160 mg – Potassium : 520 mg -  Chlorine : 340 mg -  Calcium : 500 mg -  Phosphorus : 350 mg -   Magnesium :46 mg – Iron : 7.5 mg -  Zinc : 6 mg -  Copper :0.3 mg – Iodine : 115 μg -  Manganese : 25 μg -  Selenium : 10.5 μg -  Vitamin A : 390 μg -  Vitamin D : 7.25  μg - Vitamin B1 : 0.84 μg - Vitamin B2 : 1.32 mg -  Vitamin B6 : 0.4  mg -  Vitamin B12 : 1.1 μg -  Biotin : 14.2 μg - Folic acid : 108 μg – Niacin : 3.7 mg – Pantothenic Acid :4.65 mg -  Vitamin C : 60 mg - Vitamin K : 40  μg - Vitamin E : 8 mg  – Choline : 70 mg – Inositol : 36 mg</i_keyword>
      <i_keyword>The first itervention is Bebelac 3 infant formula. At first, the participants are divided into two groups of four and two using simple random method and the interval of one week is considered as washout. In this way, each group randomly uses one of the products per week. Intervention is performed with 10 cc of one of the Infant formulas of Aptamil 3, NAN 3 and Bebelac 3 with one-week interval. The Aptamil 3 Infant formula is manufactured by Nutrition Company, NAN 3 made by Milupa, and Bebelac 3 is made by Nestle Corporation. The ingredients of the products studied are based on the information on the packaging, including protein, energy, casein, fat, linoleic acid, AA, DHA, carbohydrate, lactose, etc., as described in the table. In each session, the pH of the dental plaque base is measured by the testator at the site, in the area between the distal surface of the first premolar and the second mesenteric surface of the premolars, in all four quadrants of the mouth. The person tested then holds ten cubic meters of the infant formula in mouth for two minutes and then swallows. The pH of the plaque at designated sites of all four quadrants is measured at five, ten, twenty and sixty minutes after the application of the solution using Metrohm Microelectrode (Ω Metrohm Switzerland LL micro glass electrode) connected to the digital PH Meter (Swiss- Metrohm). It should be noted that the microelectrode is washed prior to the start of each test and at intervals of each reading with a solution 3 KCL model (pH = 7) calibrated with distilled water flow. Meanwhile, for disinfection of the electrode for intervals between the subjects, 2% glutaraldehyde solution is used for 20 minutes. The average pH at the time of the examination, separately the three materials tested in the all quadrants are determined. The results of the study were analyzed by Repeated measure ANOVA with a significance level of p &lt;0.05. Energy : 456 Kcal -  Protein : 15 gr - Whey protein : 6 gr -  Casein : 9 gr -  Fat : 19.6 gr - Linoleic acid : 2640 mg -  Alpha Linoleic Acid : 489 mg -  carbohydrates: 53.3 g -  Lactose : 50.6 g -  Fiber : 3.7 g – Sodium : 182 mg – Potassium : 730 mg -  Chlorine : 536 mg -  Calcium : 638 mg -  Phosphorus : 410 mg -  Ratio of calcium and phosphorus : 1.6 -  Magnesium : 49 mg – Iron : 6.7 mg -  Zinc : 4.4 mg -  Copper :268 μg – Iodine : 105 μg -  Manganese : 45 μg -  Selenium : 13 μg -  Vitamin A : 436 μg -  Vitamin D : 9.5  μg - Vitamin B1 : 416 μg - Vitamin B2 : 822 μg -  Vitamin B6 : 330 μg -  Vitamin B12 : 1.3 μg -  Biotin : 14 μg - Folic acid : 86 μg – Niacin : 3.1 mg – Pantothenic Acid : 2954 μg -  Vitamin C : 61 mg - Vitamin K : 33  μg - Vitamin E : 7.6 mg – Cytidine : 7.1 mg – Uridine : 5 mg – Adenosine : 4.4 mg – Guanosine : 1.5 mg -  Inosine : 2.9 mg – Taurine : 34 mg – Choline : 86 mg – Inositol : 32 mg - L-Carnitine : 9.2 mg</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Dental plaque pH. Timepoint: Before intervention and at intervals of 5-10-20-60 minutes after intervention. Method of measurement: Dental plaque pH - Microelectrode.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-10-17</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>7th Floor, Bldg No.2, Shahid Beheshti University of Medical Sciences, Arabi Ave, Daneshjoo Blvd, Velenjak, Chamran highway, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
